Skip to main content
GEVO logo

GEVO · Gevo, Inc.

Track GEVO — free
$1.83 -0.03 (-1.61%) At close · Nov 13
Market Cap
$452.70M
Shares
247.38M
Volume · Nov 13 3.93M Avg daily vol (3M) 3.41M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.83 Open$1.86 Day$1.77–1.87 52W close$1.11–2.78 Avg vol 30d4.3M Short int24.9M · 10.1% of shares · 8.4d Short vol41% Last earningsNov 10, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 10

Up next

Jan 14, 2027 Est · unconfirmed · in 9 wks

Latest documents

2026
Nov 10
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rose $40.2 million as company returned to profit

Gevo, Inc. reported a $40.2 million third-quarter revenue increase and net income of $22,714 thousand, versus a $7,954 thousand loss, returning the company to profit.

Revenue $82.95M ▲ 94.2% Net income $22.71M Diluted EPS $0.09
Read from the MD&A section
2 source passages
Operating revenue. During the three months ended September 30, 2026, operating revenue increased by $40.2 million compared to the three months ended September 30, 2025. Net income (loss) attributed to Gevo, Inc. | 22,714 | (7,954) | 30,668 | (386)% Open the document at this passage
Nov 10
Current report 8-K
Record $83 million revenue reported for third quarter 2026

Gevo reported record revenue of $83 million, net income of $23 million and non-GAAP Adjusted EBITDA of $44 million for the third quarter ended September 30, 2026. It raised 2026 Adjusted EBITDA outlook to greater than $90 million and 2027 guidance to greater than $70 million.

Financial results
2 source passages
Gevo, Inc. (NASDAQ: GEVO) today announced its financial results for the third quarter ended September 30, 2026, reporting record revenue of $83 million, net income of $23 million, non-GAAP Adjusted EBITDA1 of $44 million and cash flow from operations of $41 million. Improved non-GAAP Adjusted EBITDA1 outlook: Gevo now expects full year 2026 non-GAAP Adjusted EBITDA1 to be greater than $90 million and 2027 non-GAAP Adjusted EBITDA1 to be greater than $70 million. Open the document at this passage
Oct 28
Current report 8-K Events of Oct 23
K’Lynne Johnson appointed independent director effective November 4, 2026

Gevo appointed K’Lynne Johnson as an independent Class II director effective November 4, 2026. She will receive an $85,000 annual cash retainer and a $63,000 equity grant.

Director or officer change, or executive pay, Regulation FD disclosure
3 source passages
Effective as of November 4, 2026, the Board of Directors (the “Board”) of Gevo, Inc. (“Gevo” or the “Company”) approved the appointment of K’Lynne Johnson to the Board as a Class II director, with a current term that will expire at the annual meeting of stockholders to be held in 2027. Ms. Johnson will receive an annual cash retainer of $85,000 and an equity grant valued at $63,000 for service as a non-employee director, subject to the Company’s compensation policy for non-employee directors as specified from time to time by the Board. The Board considered the independence of Ms. Johnson under The Nasdaq Stock Market LLC (“Nasdaq”) listing standards and concluded that Ms. Johnson is an independent director under the applicable Nasdaq standards. Open the document at this passage
Aug 6
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $46.5M ▲ 7.1% Net loss $176.94M Diluted EPS -$0.75
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$217.75M
Trailing 12 months
Net income (TTM)
−$182.22M
Trailing 12 months
Revenue growth YoY
+94.2%
Year over year
Operating margin
-68.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-6.8%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$100.22M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.5%
Year over year · more shares
Price change (1Y)
-8.5%
Trailing year
Short interest
10.1%
Latest settlement · 8.4 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +8%
above
Price vs 50-day avg +33%
above
RSI (14) 73
overbought
MACD trend Positive
52-week position 43%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +56%
trailing
6-month return +3%
trailing
YTD return −9%
this year
Relative strength +3%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Distributing
127 of 149 funds reported for Sep 30 · net -10.4M sh shares · +17 new
Insider flow Accumulating
Net +$96.4K over 90 days · 0% sells
Short interest Rising
10.07% of shares out · ▲ +6.5% MoM · 8.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
149 holders — mid 3-yr range
Squeeze score 100
high risk · 0–100
Fundamentals
Weak
Revenue growth −87%
Y/Y
Gross margin -1611%
contracting
EPS growth +59%
Y/Y
Free cash flow $-43.5M
Buyback $20.3M
remaining
Balance sheet $83.6M
net debt
Quant / Vol
risk profile
Very High
Volatility 71%
annualized · 1-yr
Max drawdown −60%
past year
ATR 7.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Nov 10, 2026
full year 2026
Non-GAAP Adjusted EBITDA Non-GAAP at least $90M
2027
Non-GAAP Adjusted EBITDA Non-GAAP at least $70M
annually
45Z value at least $10M
2026
Revenue at least $50M
Previous outlook earlier release · from the 8-K filed Aug 6, 2026

Still-open targets the latest release did not restate under the same label.

Non-GAAP Adjusted EBITDA · full year 2026 at least $60M
Section 45Z tax credit monetizations · full year 2026 at least $70M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+8% Bullish
Price vs 50-day avg
+33% Bullish
RSI (14)
73 Bearish
MACD trend
Positive Bullish
52-week position
43% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Distributing
127 of 149 funds reported for Sep 30 · net -10.4M sh shares · +17 new
Insider flow Accumulating
Net +$96.4K over 90 days · 0% sells
Short interest Rising
10.07% of shares out · ▲ +6.5% MoM · 8.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
149 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1 Now $2 · 43% Range high $3
vs 200-day avg +8% vs 50-day avg +33%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Carbon sequestered (metric tons) 43,881 the three months ended June 30, 2026 filing —
Ethanol (gallons) 16,344,431 the three months ended June 30, 2026 filing —
Ethanol co-products (tons) 57,542 the three months ended June 30, 2026 filing —
LCFS generation 35,332 the three months ended June 30, 2026 filing —
Low-carbon ethanol production 16.3M Q2 2026 —
Non-GAAP Adjusted EBITDA non-GAAP $11M Q2 2026 —
Non-GAAP adjusted net (loss) income attributable to Gevo, Inc. per share non-GAAP -$0.07 Six Months Ended June 30, 2026 —
RINs Generation 1,121,858 the three months ended June 30, 2026 filing —
RNG production 95,939 Q2 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GEVO
Gevo, Inc.
this stock
$452.70M -8.5% -87.2% — 10.1%
LIN
Linde PLC
$241.51B +23.4% +3.0% 34.9 1.4%
AIQUF
L Air Liquide SA
$137.11B +14.4% — — 0.0%
ECL
Ecolab Inc.
$86.74B +17.8% +2.2% 42.1 1.5%
SHW
Sherwin Williams Co
$84.53B +8.0% +2.1% 32.2 2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
158
% held
33.6%
Reported
127 of 149
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
114
View
Short & Settlement
Short Interest Rising
Shares short
24.9M
Days to cover
8.4d
Change
+1.5M sh
View
Short Volume
Short vol %
41%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
96.8K
Value
$130.7K
As of
Oct 9, 2026
View
Off-Exchange
Off-exchange %
51.4%
Week of
Oct 5, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$96.4K
Buyers / Sellers
2 / 0
Buyers Sellers
View
Congressional Trades Buy
Member
Christopher L. Jacobs
Amount
$1.0K–$15.0K
Traded
Dec 12, 2022
View
Financials
Financials
Revenue (FY)
$160.6M
Net income (FY)
$-33.8M
EPS diluted
$-0.14
View
Buybacks
Authorized
$25.0M
Remaining
$20.3M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 10, 2026
This year
20

Gevo, Inc. reported a $40.2 million third-quarter revenue increase and net income of $22,714 thousand, versus a $7,954 thousand loss, returning the company to profit.

View
Proposed Sales
Value
$2.6K
Shares
1.5K
Filed
Sep 3, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 10, 2026
View
Investor Relations
Latest news
Gevo to Report Third Quarter 2026…
Published
Oct 29, 2026
View

Performance

5D 20D 120D MTD YTD
GEVO +31.7% +56.4% +3.4% +46.4% -8.5%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY +29.1% +57.6% +2.9% +46.6% -19.1%

Capital returns

Buyback program · as of Sep 30, 2026
Authorized
$25.00M
Spent (derived)
$4.70M
Remaining
$20.30M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1392380 CUSIP 374396406 13F (30d) 142 filings 113 filers Visit website Investor relations